#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14290	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2112	672.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1709	1709	T	731	T,C,G	679,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14290	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2112	672.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1443	1443	C	900	C,T,A	842,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26630	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3602	737.5	0	.	n	.	0	T695C	SNP	695	695	T	1055	1055	C	778	C	727	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26630	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3602	737.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2331	2331	C	804	C	749	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26630	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3602	737.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2405	2405	A	815	A,C	771,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26630	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3602	737.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2957	2957	C	855	C,T	789,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2188	folP	855	855	99.88	folP.l15.c4.ctg.1	1609	135.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1065	1067	CGC	201;201;201	C;G;C	187;186;185	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5408	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3611	149.4	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	185;183;183	T;T;C	173;171;171	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5408	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3611	149.4	1	SNP	p	D95G	0	.	.	283	285	GAC	655	657	GAC	189;190;190	G;A,C;C	174;178,1;176	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	27	5408	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3611	149.4	1	SNP	p	D95N	0	.	.	283	285	GAC	655	657	GAC	189;190;190	G;A,C;C	174;178,1;176	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1820	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1289	140.3	1	SNP	p	G45D	1	.	.	133	135	GAC	456	458	GAC	199;199;200	G;A;C	187;188;190	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	926	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1094	83.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	5030	parC	2304	2304	99.91	parC.l15.c30.ctg.1	2960	169.2	1	SNP	p	S87R	0	.	.	259	261	AGT	601	603	AGT	240;239;236	A;G;T	217;214;213	parC.WHO_L_00611c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	5030	parC	2304	2304	99.91	parC.l15.c30.ctg.1	2960	169.2	1	SNP	p	S87W	0	.	.	259	261	AGT	601	603	AGT	240;239;236	A;G;T	217;214;213	parC.WHO_L_00611c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_L_00611c	parC.WHO_L_00611c	1	1	27	5030	parC	2304	2304	99.91	parC.l15.c30.ctg.1	2960	169.2	1	SNP	p	S87I	0	.	.	259	261	AGT	601	603	AGT	240;239;236	A;G;T	217;214;213	parC.WHO_L_00611c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4574	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2705	168.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1607	1609	GGC	236;231;230	G;G;C	218;215;209	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1177	1179	GCA	230;232;234	G;C,A;A,C	209;209,1;212,1	penA.7.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1180	1182	ATC	233;233;231	A;T;C,G	215;216;210,1	penA.7.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1192	1194	GTG	221;221;224	G,A;T,C;G,C	205,1;201,1;203,1	penA.7.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1192	1194	GTG	221;221;224	G,A;T,C;G,C	205,1;201,1;203,1	penA.7.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1696	1698	ACC	220;218;215	A;C;C	202;202;201	penA.7.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1750	1752	GTG	201;196;193	G;T,G;G	184;155,6;178	penA.7.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1750	1752	GTG	201;196;193	G;T,G;G	184;155,6;178	penA.7.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1873	1875	AGC	167;165;166	A;G;C	147;150;151	penA.7.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1882	1884	GGC	157;158;155	G;G;C	146;142;139	penA.7.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.7.001	penA.7.001	1	1	27	4058	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2245	179.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1900	1902	CCG	128;131;130	C,G;C,T;G	97,4;102,1;99	penA.7.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5826	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3158	184.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1629	1631	CCG	226;222;222	C;C;G	191;201;196	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2438	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1752	138.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	363	365	GGC	144;146;145	G;G;C	139;140;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2438	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1752	138.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	545	545	C	175	C	155	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	97	99	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	100	102	AAT	5;4;4	A;A;T	5;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	112	114	GTT	4;4;4	G;T;T	4;3;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	124	126	GCG	5;5;5	G;C;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	147	149	GTA	7;7;7	G;T;A	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	N237K	NONSYN	709	711	AAC	156	158	AAA	6;6;6	A;A;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	186	porB1a	984	287	90.38	porB1a.l6.c30.ctg.2	362	9.3	0	.	p	.	0	D238fs	FSHIFT	712	712	G	159	159	G	10	G	9	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	D41K	NONSYN	121	123	GAC	338	340	AAA	227;226;229	A;A;A	213;213;214	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	644	646	CAA	216;219;220	C;A;A	201;202;205	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	851	853	GAT	219;219;222	G;A;T	204;206;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	H213D	NONSYN	637	639	CAT	854	856	GAT	225;229;230	G;A;T	211;214;213	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	V215D	NONSYN	643	645	GTT	860	862	GAT	231;229;226	G;A;T	215;211;210	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	I218M	NONSYN	652	654	ATC	869	871	ATG	235;235;233	A;T;G,A	218;221;217,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	0	.	p	.	0	R257K	NONSYN	769	771	AGG	986	988	AAG	237;241;245	A;A;G	223;228;233	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2642	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1409	184.7	1	SNP	p	G120K	0	.	.	358	360	GGC	575	577	GGC	230;227;225	G,T;G;C	212,1;210;206	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10224	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4901	208.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2005	2007	CAT	211;215;212	C;A;T	199;204;200	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1120	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1193	93.7	1	SNP	p	V57M	1	.	.	169	171	ATG	582	584	ATG	218;218;218	A,G;T;G	206,1;206;205	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
